Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)
84.47
+0.11
(+0.12%)
Streaming Delayed Price
Updated: 10:46 AM EDT, Aug 12, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 609,997 |
| Open | 84.40 |
| Bid (Size) | 84.46 (1,700) |
| Ask (Size) | 84.47 (200) |
| Prev. Close | 84.36 |
| Today's Range | 84.40 - 84.48 |
| 52wk Range | 26.50 - 84.38 |
| Shares Outstanding | 54,026,103 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday ↗
August 04, 2026
Is This Biotech Stock a Buy Near Its 52-Week High? ↗
July 10, 2026
Frequently Asked Questions
Is Crinetics Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Crinetics Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Crinetics Pharmaceuticals, Inc. - Common Stock trade on?
Crinetics Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock is CRNX on the Nasdaq Stock Market
What is the current price of Crinetics Pharmaceuticals, Inc. - Common Stock?
The current price of Crinetics Pharmaceuticals, Inc. - Common Stock is 84.47
When was Crinetics Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Crinetics Pharmaceuticals, Inc. - Common Stock was at 08/12/26 10:46 AM ET
What is the market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock is 4.56B
How many shares of Crinetics Pharmaceuticals, Inc. - Common Stock are outstanding?
Crinetics Pharmaceuticals, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
